127 related articles for article (PubMed ID: 10378478)
1. Antiestrogenicity of environmental polycyclic aromatic hydrocarbons in human breast cancer cells.
Arcaro KF; O'Keefe PW; Yang Y; Clayton W; Gierthy JF
Toxicology; 1999 Apr; 133(2-3):115-27. PubMed ID: 10378478
[TBL] [Abstract][Full Text] [Related]
2. Antiestrogenicity of clarified slurry oil and two crude oils in a human breast-cancer cell assay.
Arcaro KF; Gierthy JF; Mackerer CR
J Toxicol Environ Health A; 2001 Apr; 62(7):505-21. PubMed ID: 11289701
[TBL] [Abstract][Full Text] [Related]
3. Toxaphene is antiestrogenic in a human breast-cancer cell assay.
Arcaro KF; Yang Y; Vakharia DD; Gierthy JF
J Toxicol Environ Health A; 2000 Feb; 59(3):197-210. PubMed ID: 10667634
[TBL] [Abstract][Full Text] [Related]
4. Differential action of polycyclic aromatic hydrocarbons on endogenous estrogen-responsive genes and on a transfected estrogen-responsive reporter in MCF-7 cells.
Gozgit JM; Nestor KM; Fasco MJ; Pentecost BT; Arcaro KF
Toxicol Appl Pharmacol; 2004 Apr; 196(1):58-67. PubMed ID: 15050408
[TBL] [Abstract][Full Text] [Related]
5. Waste crankcase oil: an environmental contaminant with potential to modulate estrogenic responses.
Ssempebwa J; Carpenter D; Yilmaz B; DeCaprio A; O'Hehir D; Arcaro K
J Toxicol Environ Health A; 2004 Jul; 67(14):1081-94. PubMed ID: 15205025
[TBL] [Abstract][Full Text] [Related]
6. Review of the estrogenic and antiestrogenic activity of polycyclic aromatic hydrocarbons: relationship to carcinogenicity.
Santodonato J
Chemosphere; 1997 Feb; 34(4):835-48. PubMed ID: 9569946
[TBL] [Abstract][Full Text] [Related]
7. Antiestrogenicity of beta-naphthoflavone and PAHs in cultured rainbow trout hepatocytes: evidence for a role of the arylhydrocarbon receptor.
Navas JM; Segner H
Aquat Toxicol; 2000 Nov; 51(1):79-92. PubMed ID: 10998501
[TBL] [Abstract][Full Text] [Related]
8. Estrogenic and antiestrogenic activities of flavonoid phytochemicals through estrogen receptor binding-dependent and -independent mechanisms.
Collins-Burow BM; Burow ME; Duong BN; McLachlan JA
Nutr Cancer; 2000; 38(2):229-44. PubMed ID: 11525602
[TBL] [Abstract][Full Text] [Related]
9. Antiestrogenic effects of marijuana smoke condensate and cannabinoid compounds.
Lee SY; Oh SM; Lee SK; Chung KH
Arch Pharm Res; 2005 Dec; 28(12):1365-75. PubMed ID: 16392670
[TBL] [Abstract][Full Text] [Related]
10. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships.
Connor K; Ramamoorthy K; Moore M; Mustain M; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830
[TBL] [Abstract][Full Text] [Related]
11. Polynuclear aromatic hydrocarbon carcinogens as antiestrogens in MCF-7 human breast cancer cells: role of the Ah receptor.
Chaloupka K; Krishnan V; Safe S
Carcinogenesis; 1992 Dec; 13(12):2233-9. PubMed ID: 1335374
[TBL] [Abstract][Full Text] [Related]
12. Methylated polycyclic aromatic hydrocarbons and/or their metabolites are important contributors to the overall estrogenic activity of polycyclic aromatic hydrocarbon-contaminated soils.
Lam MM; Engwall M; Denison MS; Larsson M
Environ Toxicol Chem; 2018 Feb; 37(2):385-397. PubMed ID: 28834568
[TBL] [Abstract][Full Text] [Related]
13. 3,3'4,4'-Tetrachlorobiphenyl exhibits antiestrogenic and antitumorigenic activity in the rodent uterus and mammary cells and in human breast cancer cells.
Ramamoorthy K; Gupta MS; Sun G; McDougal A; Safe SH
Carcinogenesis; 1999 Jan; 20(1):115-23. PubMed ID: 9934858
[TBL] [Abstract][Full Text] [Related]
14. Effects of the aryl hydrocarbon receptor agonist 3-methylcholanthrene on the 17β-estradiol regulated mRNA transcriptome of the rat uterus.
Helle J; Keiler AM; Zierau O; Dörfelt P; Vollmer G; Lehmann L; Chittur SV; Tenniswood M; Welsh J; Kretzschmar G
J Steroid Biochem Mol Biol; 2017 Jul; 171():133-143. PubMed ID: 28285017
[TBL] [Abstract][Full Text] [Related]
15. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.
Ramamoorthy K; Wang F; Chen IC; Norris JD; McDonnell DP; Leonard LS; Gaido KW; Bocchinfuso WP; Korach KS; Safe S
Endocrinology; 1997 Apr; 138(4):1520-7. PubMed ID: 9075711
[TBL] [Abstract][Full Text] [Related]
16. Estrogenic activity of environmental polycyclic aromatic hydrocarbons in uterus of immature Wistar rats.
Kummer V; Masková J; Zralý Z; Neca J; Simecková P; Vondrácek J; Machala M
Toxicol Lett; 2008 Aug; 180(3):212-21. PubMed ID: 18634860
[TBL] [Abstract][Full Text] [Related]
17. Indolo[3,2-b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity.
Liu H; Wormke M; Safe SH; Bjeldanes LF
J Natl Cancer Inst; 1994 Dec; 86(23):1758-65. PubMed ID: 7966413
[TBL] [Abstract][Full Text] [Related]
18. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
19. In vitro estrogenicity of ambient particulate matter: contribution of hydroxylated polycyclic aromatic hydrocarbons.
Wenger D; Gerecke AC; Heeb NV; Schmid P; Hueglin C; Naegeli H; Zenobi R
J Appl Toxicol; 2009 Apr; 29(3):223-32. PubMed ID: 19021152
[TBL] [Abstract][Full Text] [Related]
20. Antiestrogenic activity of DP-TAT-59, an active metabolite of TAT-59 against human breast cancer.
Toko T; Shibata J; Nukatsuka M; Yamada Y
Cancer Chemother Pharmacol; 1997; 39(5):390-8. PubMed ID: 9054952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
